QA: Ardelyx INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437402_2026_Ardelyx_INC.pdf

Logs

Graph

Absolute values for 0001437402, Ardelyx INC

  xvar xval
0 AssetsCurrent 382,317,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,184,000
3 remainder_Assets 117,103,000
4 LiabilitiesCurrent 88,605,000
5 LiabilitiesNoncurrent 17,340,000
6 remainder_Liabilities 228,710,000
7 CostOfGoodsAndServicesSold 39,008,764
8 SellingGeneralAndAdministrativeExpense 598,203,722
9 ResearchAndDevelopmentExpense 69,233,544
10 remainder_Expenses 69,100,592
11 remainder_Revenues 494,129,021
12 remainder_NetIncome 8,361,296
13 remainder_ComprehensiveNetIncome -123,031
  yvar yval
0 Assets 501,604,000
1 Liabilities 334,655,000
2 Expenses 775,546,622
3 Revenues 494,129,021
4 StockholdersEquity 166,949,000
5 NetIncome -273,056,305
6 ComprehensiveNetIncome -273,117,820
7 BaseVar 1,057,209,485
8 EconomicCapitalRatiobeforeLimitedLiability 0.217
9 EconomicCapitalRatio 1.62

Edgar->Model Mapping

Feature Distribution

Change over Time